Gregg Timony
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Heat shock proteins research, Toxin Mechanisms and Immunotoxins, Protease and Inhibitor Mechanisms, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P 1 ) and receptor‐5 (S1P 5 ) agonist with autoimmune disease‐modifying activity(2016)299 cited
- → Rationally Designed High-Affinity 2-Amino-6-halopurine Heat Shock Protein 90 Inhibitors That Exhibit Potent Antitumor Activity(2007)125 cited
- → 7‘-Substituted Benzothiazolothio- and Pyridinothiazolothio-Purines as Potent Heat Shock Protein 90 Inhibitors(2006)114 cited
- → Results From the First‐in‐Human Study With Ozanimod, a Novel, Selective Sphingosine‐1‐Phosphate Receptor Modulator(2017)106 cited
- → Synthesis and Biological Evaluation of a New Class of Geldanamycin Derivatives as Potent Inhibitors of Hsp90(2004)84 cited
- → Orally Active Purine-Based Inhibitors of the Heat Shock Protein 90(2005)72 cited
- → Antiproliferatiye effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units(1998)65 cited
- → Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study(2017)59 cited
- → Pharmacokinetics, Pharmacodynamics, Allometry, and Dose Selection of rPSGL-Ig for Phase I Trial(2000)53 cited
- → Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists(2024)52 cited